Addressing Challenges and New Developments in Endometriosis Clinical Research

Over the last decade, an increasing number of drug development sponsors have conducted endometriosis clinical trials to explore more specific therapeutic targeting approaches for this chronic disease. While these changes are promising to address ongoing unmet medical needs, clinical trials continue to face many hurdles due to challenges with diagnosing patients, navigating restrictive regulatory guidelines and designing appropriate trials.